Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Downgrades Sio Gene Therapies to Sell

HC Wainwright & Co. analyst Joseph Pantginis downgrades Sio Gene Therapies (NASDAQ:SIOX) from Buy to Sell.

byBenzinga Newsdesk

April 28, 2022

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis downgrades Sio Gene Therapies (NASDAQ:SIOX) from Buy to Sell.

GM Knowingly Sold Millions of Faulty Airbags, Lawsuit Claims

By Diya Patel

Today, 5:08 AM

General Motors Company (NYSE: GM) has had a class-action lawsuit filed against them alleging that they intentionally concealed defects in airbags and seatbelts, and at least 1,298 people have died or been injured as a result.

News

Crown Electrokinetics Provides Update On Nasdaq Listing Status; Co. Has A Requested A Hearing Before A Nasdaq Hearings Panel

By Happy Mohamed

Today, 5:08 AM

Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading smart glass technology company and an expert in both designing and installing distributed antenna systems (DAS) and

CRKN